UPDATE: April 28th, 2015.
Here are the slides that EpiVax presented at the seminar:
Vaccine Design Using in Silico Tools (6.4MB)
Immunogenicity Screening and Epitope Engineering (6.3MB)

We had a great time in Seoul and we hope you did also! Thank you for your participation and engagement. If you have any questions please email info@epivax.com for a prompt reply. We hope to see you next time.

The Westin Immunogenicity Seminar Seoul is scheduled for 11 to 5 PM on the 15th of April.

Sign up now to attend!

Speakers include: Dr. Sung-Joo Lee (State of Biotechnology in S. Korea), Head of Research, Sanofi Asia Pacific R&D, Dr. Katy Park (Cancer Vaccines), Korea University College of Medicine, and Dr. Annie De Groot, CEO/CSO, EpiVax and Director and Professor, University of Rhode Island Institute for Immunology and Informatics.

The purpose of these seminars is to bridge the gap between recent academic research on in silico immunogenicity screening tools, and in vitro validation of T effectors, Tregs, Tregitopes and protein drug development (immunogenicity, deimmunization and tolerance induction). The importance of “immune camouflage” to vaccines such as the under-performing H7N9 avian influenza vaccine will also be presented and discussed.

For more information:

 Copy of 2015 02 21  Seoul Immunogenicity Agenda





Thank you for your interest, we hope to see you in Seoul, Korea.

Sign up now to attend!

For more information: Email Us Here!